Research shows that all COVID-19 vaccines authorized for use in the world provide protection against COVID-19 and J & J vaccine is one of the most recommended vaccines in the whole world and many people are preferring it, more especially because it's one jab.
CDC and other experts are continuing to assess how COVID-19 vaccines work in real-world conditions. These types of studies are called “vaccine effectiveness” studies.
But it’s not vaccines that will stop the pandemic, it’s vaccination. We must ensure fair and equitable access to vaccines, and ensure every country receives them and can roll them out to protect their people, starting with the most vulnerable.
Bad news for J&J vaccine this morning is that it could be linked to another clotting condition in European Union. The vaccines from both AstraZeneca and Johnson & Johnson have previously been associated with rare incidents of blood clotting.
Content created and supplied by: Mukona94 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More